Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science

Cure Ventures has closed an inaugural $350 million fund to provide another financial lifeline to biotech startups, with a seasoned leadership team that plans to wield smaller seed rounds to elevate larger breakthroughs.